Ht-Logo-gigapixel-icon
Ht-Logo-gigapixel-icon
Tuesday, April 8, 2025

Canada’s Politics and Government News Source Since 1989

Latest Paper

Read the latest Election 2025 stories

Tuesday, April 8, 2025 | Latest Paper
Subscribe Now

TRENDING:

Jason Field

Why retaliatory tariffs could cost lives and what we should do instead

  • For Canada’s life sciences sector, the stakes are even higher in the trade war with the U.S.—both livelihoods and lives are at risk.
Opinion | BY JASON FIELD | April 2, 2025
Mark Carney
Mark Carney
Prime Minister Mark Carney must carefully consider the unintended consequences of targeting pharmaceuticals and medical devices in retaliatory tariffs, which could disrupt supply chains, lead to drug shortages, and deter clinical trial investments, writes Jason Field. The Hill Times photograph by Andrew Meade

Why retaliatory tariffs could cost lives and what we should do instead

Opinion | BY JASON FIELD | April 2, 2025
  • For Canada’s life sciences sector, the stakes are even higher in the trade war with the U.S.—both livelihoods and lives are at risk.

Why retaliatory tariffs could cost lives and what we should do instead

Opinion | BY JASON FIELD | April 2, 2025
  • For Canada’s life sciences sector, the stakes are even higher in the trade war with the U.S.—both livelihoods and lives are at risk.
Mark Carney
Prime Minister Mark Carney must carefully consider the unintended consequences of targeting pharmaceuticals and medical devices in retaliatory tariffs, which could disrupt supply chains, lead to drug shortages, and deter clinical trial investments, writes Jason Field. The Hill Times photograph by Andrew Meade

Unlocking Canada’s greatest economic potential: life sciences

  • The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can
Opinion | BY ALISON SYMINGTON, JASON FIELD | September 18, 2024
Since the COVID-19 pandemic, the life sciences sector has been in the spotlight as a strategic economic and national security priority for Canada, write Alison Symington and Jason Field. Pexels photograph by Tara Winstead

Unlocking Canada’s greatest economic potential: life sciences

Opinion | BY ALISON SYMINGTON, JASON FIELD | September 18, 2024
  • The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can

Unlocking Canada’s greatest economic potential: life sciences

Opinion | BY ALISON SYMINGTON, JASON FIELD | September 18, 2024
  • The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can
Since the COVID-19 pandemic, the life sciences sector has been in the spotlight as a strategic economic and national security priority for Canada, write Alison Symington and Jason Field. Pexels photograph by Tara Winstead

PMPRB vacancies offer an opportunity for a course correction

  • The Patented Medicine Prices Review Board just needs to stop trying to push an agenda and go back to doing its job as an
Opinion | BY JASON FIELD | April 12, 2023
Health Minister Jean-Yves Duclos was acting in the best interest of Canadians when he proactively reached out to fulfill the Patent Act requirements after the PMPRB refused to consult him directly, writes Jason Field. The Hill Times photograph by Andrew Meade

PMPRB vacancies offer an opportunity for a course correction

Opinion | BY JASON FIELD | April 12, 2023
  • The Patented Medicine Prices Review Board just needs to stop trying to push an agenda and go back to doing its job as an

PMPRB vacancies offer an opportunity for a course correction

Opinion | BY JASON FIELD | April 12, 2023
  • The Patented Medicine Prices Review Board just needs to stop trying to push an agenda and go back to doing its job as an
Health Minister Jean-Yves Duclos was acting in the best interest of Canadians when he proactively reached out to fulfill the Patent Act requirements after the PMPRB refused to consult him directly, writes Jason Field. The Hill Times photograph by Andrew Meade

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

  • When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of
Opinion | BY JASON FIELD | June 30, 2022
The changes add several lower-priced countries to the basket of those to which Canada’s prices must be compared to determine the maximum permissible price, while removing the U.S. and Switzerland from the mix to lower the price ceiling. Unsplash photograph by Laurynas Mereckas

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

Opinion | BY JASON FIELD | June 30, 2022
  • When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

Opinion | BY JASON FIELD | June 30, 2022
  • When there is uncertainty, businesses of any kind have to assume and prepare for the worst. This is especially true when investing billions of
The changes add several lower-priced countries to the basket of those to which Canada’s prices must be compared to determine the maximum permissible price, while removing the U.S. and Switzerland from the mix to lower the price ceiling. Unsplash photograph by Laurynas Mereckas

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

  • When reports of a new respiratory disease first emerged in January 2020, it was difficult to imagine the level of social and economic disruption
Opinion | BY JASON FIELD | July 8, 2021
Periods of crisis create opportunities to re-evaluate policies, adapt practices, and consider new approaches. COVID-19 has shown us we can be very nimble when necessary, including by compressing processes into weeks or days what would normally have taken months or years. The Hill Times photograph by Andrew Meade

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

Opinion | BY JASON FIELD | July 8, 2021
  • When reports of a new respiratory disease first emerged in January 2020, it was difficult to imagine the level of social and economic disruption

Ottawa’s next steps on life sciences a turning point for health system, economic and societal recovery from COVID-19

Opinion | BY JASON FIELD | July 8, 2021
  • When reports of a new respiratory disease first emerged in January 2020, it was difficult to imagine the level of social and economic disruption
Periods of crisis create opportunities to re-evaluate policies, adapt practices, and consider new approaches. COVID-19 has shown us we can be very nimble when necessary, including by compressing processes into weeks or days what would normally have taken months or years. The Hill Times photograph by Andrew Meade

Cheaper isn’t always better, and prescription drugs are no exception

  • Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.
Opinion | BY JASON FIELD | December 15, 2017
The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade

Cheaper isn’t always better, and prescription drugs are no exception

Opinion | BY JASON FIELD | December 15, 2017
  • Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.

Cheaper isn’t always better, and prescription drugs are no exception

Opinion | BY JASON FIELD | December 15, 2017
  • Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.
The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Follow us

Advertise

get help

Subscribe
CloseMenu